Suppr超能文献

新辅助放化疗治疗胰头癌术前胆道引流中塑料支架与金属支架的比较。

Comparison of plastic stent versus metal stent in preoperative biliary drainage for pancreatic head cancer with neoadjuvant chemoradiotherapy.

机构信息

Departments of Gastroenterology and Neurology, Kagawa University, Miki, Japan.

Gastroenterological Surgery, Kagawa University, Miki, Japan.

出版信息

J Hepatobiliary Pancreat Sci. 2021 Oct;28(10):856-863. doi: 10.1002/jhbp.929. Epub 2021 Mar 12.

Abstract

BACKGROUND

While neoadjuvant chemotherapy and chemoradiotherapy (NACRT) for pancreatic head cancer are effective, preoperative endoscopic biliary drainage (EBD) is necessary for managing obstructive jaundice and cholangitis during the preoperative waiting period. Nevertheless, ideal choice of stent type is unclear. We compared plastic stents (PS) and metal stents (MS) in these situations.

METHODS

We retrospectively studied 43 patients who successfully underwent preoperative EBD prior to NACRT for pancreatic head cancer at a single institution. We divided patients into PS (n = 22) and MS (n = 21) groups. The primary outcome was the rate of re-interventional drainage rate before surgery. Secondary outcomes were rates of EBD-associated and postoperative complications and total costs in the pre- and perioperative periods.

RESULTS

The re-intervention rate was significantly greater in the PS group than in the MS group (95% vs 4.8%, respectively, P < 0.05). EBD-associated and postoperative complications were significantly less common in the MS group (P < 0.05). The average total preoperative medical costs were significantly lower in the MS group (PS vs MS: 528,597 vs 395,891 JPY, P = 0.004).

CONCLUSIONS

MS can be the first choice for EBD in patients undergoing NACRT for pancreatic head cancer. MS may be less costly overall.

摘要

背景

尽管新辅助化疗和放化疗(NACRT)对胰头癌有效,但在术前等待期间,为了治疗阻塞性黄疸和胆管炎,需要进行术前内镜胆道引流(EBD)。然而,目前尚不清楚哪种支架类型是理想的选择。我们比较了在这些情况下塑料支架(PS)和金属支架(MS)的应用。

方法

我们回顾性研究了在单一机构中,43 例成功接受胰头癌 NACRT 术前 EBD 的患者。我们将患者分为 PS(n=22)和 MS(n=21)组。主要结局是手术前再介入引流率。次要结局是 EBD 相关和术后并发症的发生率以及术前和围手术期的总费用。

结果

PS 组的再干预率明显高于 MS 组(95% vs 4.8%,P<0.05)。MS 组 EBD 相关和术后并发症明显较少(P<0.05)。MS 组的平均术前总医疗费用明显较低(PS 组 vs MS 组:528597 日元 vs 395891 日元,P=0.004)。

结论

MS 可作为接受 NACRT 的胰头癌患者 EBD 的首选方法。MS 可能总体上更具成本效益。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验